Search

Search results

179 results found

Talia Zenlea, M.D.

Person: Gastroenterologist, Women's College Hospital, Founder, BellyBlog.ca

Dr. Zenlea received her medical degree from the University of Vermont. She completed her residency in internal Medicine at Yale University/Yale-New Haven Hospital, where she served as Chief Resident, followed by 3 years of subspecialty training in gastroenterology at Harvard University/Beth Israel...

Joseph Frasca, M.D.

Person: Gastroenterologist, Rush University Medical Center, Assistant Professor, Department of Internal Medicine

Dr. Frasca’s academic interests are focused on several areas in inflammatory bowel disease (IBD), including the role of diet and obesity, geographic determinants of outcomes, quality improvement, pharmacokinetics of current IBD medications, and clinical trials for new IBD therapies.

Shana T. Rakowsky, M.D.

Person: Gastroenterologist, Beth Israel Deaconess Medical Center

Can we cure autoimmune hepatitis?

Publication: Journal Article

Longhi, Maria Serena, Lina Zhang, Giorgina Mieli-Vergani, and Diego Vergani. 2025. “Can We Cure Autoimmune Hepatitis?”. Current Opinion in Immunology 96: 102609.

HLA alleles predisposing to autoimmunity are linked to impaired immunoregulation in patients with juvenile autoimmune liver disease and in their first-degree relatives.

Publication: Journal Article

Wang, Pengyun, Muhammed Yuksel, Stella Gabeta, Jonathon Graham, Munther Hussain, Laura Jayne Blackmore, Xiaohong Huang, et al. 2025. “HLA Alleles Predisposing to Autoimmunity Are Linked to Impaired Immunoregulation in Patients With Juvenile Autoimmune Liver Disease and in Their First-Degree Relatives.”. Journal of Autoimmunity 154: 103436.

Rome Foundation Working Team Report on overlap in disorders of gut-brain interaction.

Publication: Journal Article

Barbara, Giovanni, Imran Aziz, Sarah Ballou, Lin Chang, Alexander C Ford, Shin Fukudo, Samuel Nurko, et al. 2025. “Rome Foundation Working Team Report on Overlap in Disorders of Gut-Brain Interaction.”. Nature Reviews. Gastroenterology & Hepatology 22 (4): 228-51.

Anti-tumor Necrosis Factor Drug Concentration Is Not Associated with Disease Outcomes in Pouchitis: A Retrospective, International Study.

Publication: Journal Article

Honap, Sailish, Bénédicte Caron, Jacob E Ollech, Maya Fischman, Konstantinos Papamichael, Djuna De Jong, Krisztina B Gecse, et al. 2025. “Anti-Tumor Necrosis Factor Drug Concentration Is Not Associated With Disease Outcomes in Pouchitis: A Retrospective, International Study.”. Digestive Diseases and Sciences 70 (4): 1320-27.

Generative Artificial Intelligence Tools in Gastroenterology Training.

Publication: Journal Article

Ahmed, Tasnim, Loren G Rabinowitz, Adam Rodman, and Tyler M Berzin. 2024. “Generative Artificial Intelligence Tools in Gastroenterology Training.”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 22 (10): 1975-78.

Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease.

Publication: Journal Article

Abadir, Alexander, Angela Troia, Hyder Said, Spurthi Tarugu, Benjamin C Billingsley, Nathan Sairam, Scott B Minchenberg, et al. 2024. “Factors Associated With Delays in Initiating Biologic Therapy in Patients With Inflammatory Bowel Disease.”. Digestive Diseases and Sciences 69 (8): 2796-2803.

ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment.

Publication: Journal Article

Adamina, Michel, Silvia Minozzi, Janindra Warusavitarne, Christianne Johanna Buskens, Maria Chaparro, Bram Verstockt, Uri Kopylov, et al. 2024. “ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment.”. Journal of Crohn’s & Colitis 18 (10): 1556-82.